Annual treatment requirements between CF patients with BCC infection and matched controls with P aeruginosa infection
| B cenocepacia(n = 27) | P aeruginosa(n = 27) | Estimated differenceP aeruginosa v B cenocepacia(n = 27) | p value | B multivorans(n = 8) | P aeruginosa (n = 8) | Estimated differenceP aeruginosa v B multivorans(n = 8) | p value | |
|---|---|---|---|---|---|---|---|---|
| Results expressed as mean (SD) or median (range)* and estimated mean or median differences between the groups (P aeruginosavB cenocepacia or P aeruginosavB multivorans) and 95% confidence intervals or ranges. | ||||||||
| Exacerbations | 5.5 (2.4) | 5.2 (3.2) | –0.3 (–1.8 to +1.2) | 0.66 | 5.5 (4.2) | 4.9 (3.4) | –0.5 (–4.8 to +3.7) | 0.77 |
| Clinic visits | 12.6 (5.3) | 9.2 (4.8) | –3.5 (–5.9 to –1.1) | <0.01 | 12.1 (6.7) | 11.6 (7.8) | –0.5 (–8.6 to +7.5) | 0.88 |
| Inpatient days* | 27.8 (0 to 91.4) | 17.4 (0 to 247.0) | –2.6 (–91.4 to +214.2) | 0.81 | 12.2 (1.4 to 118.0) | 5.5 (0 to 61.5) | –7.2 (–115.5 to +53.7) | 0.48 |
| Intravenous antibiotics* | 45.2 (0 to 147.0) | 44.0 (0 to 265.0) | 0 (–126.4 to +226.4) | 0.75 | 19.6 (9.0 to 171.0) | 15.3 (0 to 136.0) | –10.6 (–154.0 to +111.5) | 0.40 |